Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility

L. M. Osborn, C. Lenarsky, R. C. Oakes, M. I. Reiff

    Research output: Contribution to journalArticlepeer-review

    32 Scopus citations

    Abstract

    Current guidelines for treatment of hemolytic disease of the newborn make no differentiation between ABO and Rh incompatibility. A protocol that prolonged the observation period in full-term, ABO-incompatible infants with positive Coombs' tests who were otherwise healthy was tested. Postponement of treatment made it possible to determine more accurately which infants needed phototherapy. This dramatically decreased the number of infants treated without increasing their risk of requiring exchange transfusion.

    Original languageEnglish (US)
    Pages (from-to)371-374
    Number of pages4
    JournalPediatrics
    Volume74
    Issue number3
    StatePublished - Jan 1 1984

    Fingerprint

    Dive into the research topics of 'Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility'. Together they form a unique fingerprint.

    Cite this